RJFSA
NVAX icon

Raymond James Financial Services Advisors’s Novavax NVAX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$149K Buy
11,805
+1,131
+11% +$14.6K ﹤0.01% 3238
2024
Q2 		$135K Buy
+10,674
New +$107K ﹤0.01% 3193
2023
Q4 		– Sell
-10,508
Closed -$76.1K – 3384
2023
Q3 		$76.1K Buy
+10,508
New +$84K ﹤0.01% 3109
2023
Q1 		– Sell
-50,006
Closed -$514K – 3361
2022
Q4 		$514K Sell
50,006
-5,582
-10% -$98.5K ﹤0.01% 2246
2022
Q3 		$1.01M Buy
55,588
+10,542
+23% +$457K ﹤0.01% 1802
2022
Q2 		$2.32M Buy
45,046
+15,335
+52% +$794K 0.01% 1361
2022
Q1 		$2.19M Buy
29,711
+3,536
+14% +$315K ﹤0.01% 1430
2021
Q4 		$3.75M Buy
26,175
+8,152
+45% +$1.4M 0.01% 1160
2021
Q3 		$3.74M Buy
18,023
+373
+2% +$82.2K 0.01% 1127
2021
Q2 		$3.75M Sell
17,650
-3,196
-15% -$586K 0.01% 1120
2021
Q1 		$3.78M Sell
20,846
-1,370
-6% -$273K 0.01% 1036
2020
Q4 		$2.48M Buy
22,216
+1,573
+8% +$167K 0.01% 1179
2020
Q3 		$2.24M Sell
20,643
-2,409
-10% -$293K 0.01% 1112
2020
Q2 		$1.92M Buy
23,052
+9,714
+73% +$372K 0.01% 1143
2020
Q1 		$181K Buy
+13,338
New +$113K ﹤0.01% 2101
2019
Q2 		– Sell
-3,796
Closed -$42K – 2897
2019
Q1 		$42K Sell
3,796
-1,196
-24% -$37.8K ﹤0.01% 2717
2018
Q4 		$184K Sell
4,992
-260
-5% -$10.1K ﹤0.01% 2285
2018
Q3 		$197K Buy
5,252
+92
+2% +$2.59K ﹤0.01% 2537
2018
Q2 		$138K Buy
5,160
+75
+1% +$2.54K ﹤0.01% 2560
2018
Q1 		$214K Sell
5,085
-125
-2% -$5.02K ﹤0.01% 2214
2017
Q4 		$129K Buy
5,210
+250
+5% +$6.1K ﹤0.01% 2347
2017
Q3 		$113K Buy
4,960
+475
+11% +$10.6K ﹤0.01% 2378
2017
Q2 		$103K Buy
4,485
+1,490
+50% +$29.2K ﹤0.01% 2340
2017
Q1 		$77K Buy
2,995
+10
+0.3% +$275 ﹤0.01% 2287
2016
Q4 		$75K Sell
2,985
-740
-20% -$21.6K ﹤0.01% 2215
2016
Q3 		$155K Buy
3,725
+1,990
+115% +$257K ﹤0.01% 2096
2016
Q2 		$252K Buy
1,735
+1,195
+221% +$137K ﹤0.01% 1830
2016
Q1 		$56K Buy
+540
New +$57.9K ﹤0.01% 1955

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Raymond James Financial Services Advisors's NVAX Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Novavax (NVAX) stake by 11% in Q3 2024, buying an estimated $14.6K and bringing the position to 11,805 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #3238.

Raymond James Financial Services Advisors first reported a position in NVAX in Q1 2016 and has held it in 28 quarters since. The position peaked at $3.78M in Q1 2021. 238 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Raymond James Financial Services Advisors held 11,805 shares of Novavax worth $149K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 1,131 Novavax shares in Q3 2024, an estimated $14.6K.
  • Novavax made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3238 holding.
  • Raymond James Financial Services Advisors first reported a position in Novavax in Q1 2016 and has held it in 28 quarters since.
  • Raymond James Financial Services Advisors's Novavax position peaked at $3.78M in Q1 2021.
  • 238 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.